Four reasons why outsourcing may be the best option, and key factors to consider when selecting a provider.
Understanding the impact on process performance.
An alternative approach to traditional Protein A schemes is comparable in overall efficiency, product recovery, and quality.
Scalable method to recover plasmid-DNA.
A close-up look at Pfizer's biotherapeutics plant in Shanbally, Ireland.
FDA perspectives on specs and effective control strategies.
The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.
How to maintain product stability and prevent particulates.
Recent technological advances in the way biologic therapeutics are purified may bring size-exclusion chromatography back into the modern purification process.
Understanding the impact on process performance.
Using chemically defined feeds with CHO cell lines not only eliminates the variability associated with using plant hydrolysates, but could also improve the productivity of biopharmaceutical protein manufacture and help move therapeutic proteins into clinical trials more rapidly.
Data on the performance and variability of different formats.
The disadvantages of the traditional vaccine regime (prime plus boost) have spurred the development of single-shot vaccines. This article describes the development and manufacture of a prototype single-shot vaccine that uses microspheres made from cross-linked modified dextran polymers for controlled release of the antigen.
Data on the performance and variability of different formats.
By providing information on the relative accessibility of locations within a protein, HDX by mass spectrometry opens new windows into the higher order structure of biomolecules.
The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.
A membrane adsorber in retention mode can be used efficiently in a commercial antibody manufacturing process.
Data on the performance and variability of different formats.
Precipitation prior to capture chromatography offers a simple, robust, and economical method to remove CHO host cell proteins and DNA.
Learn the latest techniques for improved chromatographic performance and throughput of AAV analysis.
Scalable method to recover plasmid-DNA.
A comparison of primary harvest techniques.
Membrane chromatography ensures purity at high flow rates.
This article describes the steps required to build a comprehensive model in a batch process simulator for a process that uses single-use systems for buffer preparation and storage.
A top-10 list of critical legal issues that biotech start-ups should make an effort to address, even when the capital squeeze is intense.